Product Information
VENLAFAXINE HCL ER 75 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0822 per EA under NDC 31722000390. Its NADAC has been published 294 times since Nov 11, 2020.
Strength
75 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722000390
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212277On Market Since
7/8/2019
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 75 MG CAP has been published 294 times since Nov 11, 2020, and over the history we have for it it has declined 42.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0822 per EA |
|---|---|
| All-time high | $0.1422 (Nov 11, 2020) |
| All-time low | $0.0759 (Nov 20, 2024) |
| 52-week high | $0.0959 |
| 52-week low | $0.0822 |
| Median price | $0.1085 |
| Average price | $0.1074 |
| Largest weekly change | +25.7% (Aug 21, 2024) |
| Weeks tracked | 294 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 75 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.0822 per EA (NDC 31722000390), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 75 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 75 MG CAP has declined 42.2%. It has been tracked across 294 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 75 MG CAP?
Since Nov 11, 2020, the NADAC for VENLAFAXINE HCL ER 75 MG CAP has ranged from a low of $0.0759 (Nov 20, 2024) to a high of $0.1422 (Nov 11, 2020), with a median of $0.1085 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 75 MG CAP?
10 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 75 MG CAP, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 75 MG CAP?
VENLAFAXINE HCL ER 75 MG CAP (NDC 31722000390) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification